 |
One, two, three, or four antisense oligonucleotides of Phosphorodiamidate morpholino oligomer combination that skips exons 4, 5, 6, and 7 of the gamma sarcoglycan (SGCG) gene |
|---|---|
| Trade Name | |
| Orphan Indication | Limb-girdle muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-18 00:00:00 |
| Sponsor | Kurt+Peter Foundation;P. O. Box 691;Menlo Park, California, 94025 |
